Description of the Company. The Company is a public limited company and the ultimate holding company of the Group, an international banking and financial services group particularly focused on the markets of Asia, Africa and the Middle East. The Company was incorporated in England and Wales as a limited company in 1969. Description of the Securities U.S.$1,500,000,000 Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities. Issue Date 19 August 2021. Perpetual Securities The Securities are perpetual securities and have no fixed maturity or fixed redemption date. Issue Price 100 per cent. Initial Fixed Interest Rate The Securities bear interest in respect of the period from (and including) the Issue Date to (but excluding) 19 February 2029 at a fixed rate of 4.30 per cent. per annum, being (i) the semi-annual equivalent yield to maturity of the relevant U.S. Treasury securities, determined on 10 August 2021 and in a manner consistent with that set out in the definition of “Treasury Yield” below, plus (ii) the Margin. For these purposes:
Description of the Company. The Company is a corporation organized and existing under the laws of the State of Delaware, having its registered office and principal place of business at The issued and paid-up shares of stock of Company are 100 common share, all of which are legally or beneficially owned by the Seller(hereinafter called the "Shares").
Description of the Company. The Company is a public limited company and the ultimate holding company of the Group, an international banking and financial services group particularly focused on the markets of Asia, Africa and the Middle East. The Company was incorporated in England and Wales as a limited company in 1969. Description of the Securities U.S.$1,250,000,000 Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities.
Description of the Company. The Company is a stock corporation, duly established and validly existing under the laws of Austria, with corporate seat in Vösendorf and business address at Xxxxxxxxxx 00, 0000 Xxxxxxxxx, Xxxxxxx, registered with the county court of Wiener Neustadt under registration number FN 99090 x.
Description of the Company. The condition (financial or otherwise) of the Company, the business of the Company and the terms and provisions of the Declaration of Trust conform in all material respects to the descriptions thereof contained in the Registration Statement and the Prospectus.
Description of the Company. 1. Persons responsible The Directors, whose names are set out in Part I-14 "The Directors" of this document, and the Company accept responsibility for the information contained in this prospectus. To the best of the knowledge of the Directors and the Company (each of whom has taken all reasonable care to ensure that such is the case), the information contained in this prospectus is in accordance with the facts and does not omit anything likely to affect the import of such information.
Description of the Company. The Company has been formed as a newly established limited liability company under the laws of the Cayman Islands with an authorized capital of US$20 million, divided into 200,000,000 shares of common stock of par value US$0.10 each, of which 200 shares have been issued at a subscription price of US$2.50 per share and held by InFocus Cayman and TCL Optoelectronic or its Permitted Transferee on a 50/50 basis.
Description of the Company. A detailed description of the Company's business as well as the risks associated with the Company's proposed operations and its financial condition is described in Exhibit "A" annexed to this Agreement as an exhibit and the text of which is incorporated herein by this reference (the "Exhibit"). The Subscriber hereby acknowledges receipt of the Exhibit and represents that the Subscriber has read the same prior to the signing of this Agreement. In addition, and simultaneously with the delivery of this Agreement, the Company has afforded the Subscriber the opportunity to ask questions of and receive answers from management of the Company concerning the information disclosed in the Exhibit.
Description of the Company. The Company is engaged in the development, manufacturing, marketing and sales of anti-microbial and infection control silver embedded clothing for the sports market including towels and clothing for all sports. The Company has the non- exclusive license from Noble Biomaterials, Inc.(“ Noble”), the owner of several patents pertaining to the use of silver embedded thread in clothing, towels and various other anti-microbial and infection control garments, to manufacture and sell silver thread embedded towels. The Company is currently negotiating with Noble for the exclusive license but there can be no assurances that it can be obtained.
Description of the Company. The Company believes it is the leading developer of proprietary internet-based document exchange and e-signature technology solutions. Its technology can be applied to any document requiring authentication, verification and document process flow. The Company is marketing its products to a growing network of U.S. based industries including the in-home patient industry. The network, consisting of Home Healthcare Agencies ("HHAs"), Durable Medical Equipment Agencies ("DMEs"), Hospices and their referring physician base, is highly regulated. In-home patient services are extremely paper intensive to provider and physician staffs. Numerous reviews and signatures are required from various personnel such as doctors, nurses and administrators. The Company believes healthcare has lagged behind other industries as it relates to technology and workflow efficiencies resulting in increased cost structure, delayed reimbursements and reduced cash flows. Additionally, the industry is exposed to regulatory issues for mishandling of patient records and reimbursement claims procedures as well as subsequent Medicare fraud and abuse or allegations thereof. Home healthcare providers are served by practice management software offered to each segment of the industry by numerous vendors including various home-grown systems. The Company believes these vendors offer some but not all of the functionality needed by the providers' offices. The Company believes the dominant solutions providers to this industry are: McKesson Siemens Patient Care Technologies, Inc Lewis Misys Healthcare Systems Beyond Now (Cernex) Infosys Computer Unlimited Fastrack CareCentric Internally developed solutions are utilized by larger organizations such as: Gentiva Health Services Amedisys Inc. Interim/Spherion Apria Healthcare Rotech Healthcare, Inc. Lincare The Company believes that Practice Management Software is a mature market and offers homecare providers a range of solutions with various functionalities including documenting patient records required by the Center for Medicare and Medicaid Services ("CMS"), billing and scheduling. Because of the maturation of the industry, the Company believes there is little differentiation or competitive advantage among solution providers. The Company believes it offers one of the only solutions addressing the problem of efficient handling and transferring of an endless number of forms and documents used by the targeted industry. Without SecureCare, documents such as v...
